Pharmaceutical Investing Aquinox and Astellas Announce Exclusive Licensing Agreement for Rosiptor in the Asia-Pacific Region Including Japan
Pharmaceutical Investing INSYS Therapeutics Announces Exclusive License Partnership with Lunatus to Commercialize SUBSYS® (fentanyl sublingual spray) in the Middle East
HTG Molecular Diagnostics and Firalis Announce an Agreement Enabling Firalis’ Commercialization of Theranostic and Research Products and Services Based on HTG EdgeSeq Technology
Daré Bioscience Enters into Exclusive Worldwide License Agreement for Juniper Pharmaceuticals’ Intravaginal Ring (IVR) Technology Platform
Pharmaceutical Investing Basilea licenses late-stage oncology drug candidate derazantinib from ArQule
Cesca Therapeutics Announces Financial Results for the Transition Period July 1, 2017 to December 31, 2017
Blockchain Investing BLOK Technologies Enters into Letter of Intent to Acquire Mobile Banking and Payment Platform SimpleBlock
